Technology, Information, and Service for Life Science  CareTIS, Co., Ltd.

HOME ABOUT CARETIS CORE TECHNOLOGY BUSINESS SOLUTION SERVICES CONTACT US

HOME (TOP)

ABOUT Caretis

CORE TECHNOLOGY

BUSINESS SOLUTION

SERVICES

CONTACT US


Core Technology/seeds

■Diagnosis Technology
Immuno-PCR
Development process
 The “imTag PCR” applies the technology of “Immuno-PCR” to detect an antigen of an existing infinitesimal antigen in a sample. This “Immuno-PCR” is the technology that Sano et al. reported in 1992. It is a detection technology that has both peculiarity of antigen-antibody reaction and the superior detection sensitivity that PCR method has. In this way, it was superior technology. But there were some problems in detection sensitivity and quantification.
 We have resolved these problems by performing improvement of solid-phase materials and blocking agent, nucleic acid tag connected in an secondary antibody and sell it as a kit.
Performance


Confirmation of high sensitivity

“imTag-PCR” enables to get more than 1,000-times sensitivity
compared with the conventional way(ELISA).



《More adaption》
・Infectious and allergic diseases

The characteristics of “Immuno-PCR”

ELISA Immuno-PCR Superiority
time 1~4hours Within 30 min. Swift
sensitivity >ng/ml <pg/ml High sensitivity
(>1,000times)
other merit It can measure plural items
at a time
Reasonable
accuracy

Product


Brand name: “imTag PCR”